课题基金 / 基金详情

GENE EXPRESSION AND ACETAMINOPHEN

GENE EXPRESSION AND ACETAMINOPHEN
基因表达和对乙酰氨基酚
批准号:
7625594
负责人:
PAUL B WATKINS
金额:
$29.94万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

PAUL B WATKINS的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是了解使用最大推荐剂量的对乙酰氨基酚(每天4g)治疗7天是否会导致人类血液中基因表达的变化。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to see if whether 7 days of treatment with the maximun recommended dose of acetaminophen (4g per day) will produce changes in gene expression in human blood.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECT OF ACETAMINOPHEN (TYLENOL) ON HUMAN LYMPHOCYTES
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY
UNC Clinical Translation Science Award-K12 Scholars Program (KL2)
ACETAMINOPHEN (TYLENOL?) INDUCED HUMAN LYMPHOCYTE TOXICITY
海外基金